Conditions: Advanced Solid Cancers Metastatic Cancer
Keywords: Advanced and/or Metastatic solid cancers
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 11
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine safety, tolerability and maximum tolerated dose of BMS-863233 in subjects advanced and/or Metastatic solid tumors.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Cdc7-inhibitor
Intervention descriptions: intervention 1: Capsules, Oral, QD x 14 days until MTD is reached, 14d per 28 day cycle/QD 12 months

Protocol document: